Literature DB >> 31584466

Association of striatal dopaminergic neuronal integrity with cognitive dysfunction and cerebral cortical metabolism in Parkinson's disease with mild cognitive impairment.

Heeyoung Kim1, Minyoung Oh2, Jungsu S Oh2, Hyojeong Moon3, Sun Ju Chung4, Chong Sik Lee4, Jae Seung Kim2.   

Abstract

OBJECTIVES: Cognitive impairment is a common non-motor feature of Parkinson's disease (PD). However, the underlying pathophysiology of cognitive decline is unclear. We investigated the association of striatal dopamine transporter (DAT) loss with cognitive function and cerebral cortical metabolism in PD.
METHODS: Twenty-eight patients (63.1 ± 7.1 yrs, M:F = 15:13) with advanced stage of PD were enrolled, including 15 (53.6%) diagnosed with mild cognitive impairment (MCI). All patients underwent FP-CIT PET/CT, neuropsychological tests, and FDG PET/CT within a 2-week interval. We calculated the specific to non-specific binding ratio on FP-CIT PET images in 12 striatal subregional VOIs, using one occipital VOI template as a reference. Age-adjusted normalized specific to non-specific binding ratios (%BRs) of striatal subregions were compared in two groups: PD with MCI versus PD (without cognitive impairment).
RESULTS: There were no statistical differences in age, age at onset, disease duration, motor symptoms, or level of education between the two groups. The PD with MCI had lower %BRs in all striatal subregions (P < 0.05) except the posterior putamen, compared with the PD. Striatal DAT availability correlated with frontal/executive function (r = 0.567, P = 0.003) and visuospatial function (r = 0.614, P = 0.001) but not with memory function. Dopamine transporter binding of striatal subregions also correlated with posterior cortical metabolism.
CONCLUSION: This study suggest that DAT loss in the striatum, except in the posterior putamen, is associated with cognitive dysfunction, specifically frontal/executive function and visuospatial function in PD subjects.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31584466     DOI: 10.1097/MNM.0000000000001098

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  4 in total

1.  Distribution of α-Synuclein Aggregation in the Peripheral Tissues.

Authors:  Yan-Yan Li; Tian-Tian Zhou; Yi Zhang; Nai-Hong Chen; Yu-He Yuan
Journal:  Neurochem Res       Date:  2022-03-28       Impact factor: 3.996

2.  Psychedelic Treatment for Trauma-Related Psychological and Cognitive Impairment Among US Special Operations Forces Veterans.

Authors:  Alan K Davis; Lynnette A Averill; Nathan D Sepeda; Joseph P Barsuglia; Timothy Amoroso
Journal:  Chronic Stress (Thousand Oaks)       Date:  2020-07-08

3.  Dopaminergic and Metabolic Correlations With Cognitive Domains in Non-demented Parkinson's Disease.

Authors:  Linlin Han; Jiaying Lu; Yilin Tang; Yun Fan; Qisi Chen; Ling Li; Fengtao Liu; Jian Wang; Chuantao Zuo; Jue Zhao
Journal:  Front Aging Neurosci       Date:  2021-02-16       Impact factor: 5.750

Review 4.  Dopamine Transporter Imaging, Current Status of a Potential Biomarker: A Comprehensive Review.

Authors:  Giovanni Palermo; Sara Giannoni; Gabriele Bellini; Gabriele Siciliano; Roberto Ceravolo
Journal:  Int J Mol Sci       Date:  2021-10-18       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.